That's the fault of the FDA who failed Relenza and patients by not accepting proposals for clinical trials using Relenza as an IV delivery... even the recommendation to the US president stating the FDA should accelerate a decision on IV relenza hasn't made an impact. It's time that the FDA gets a major look at, or the world looks for another agency. The FDA is simply not keeping up with the times.
- Forums
- ASX - By Stock
- fda, glaxo warn of death due to anti-flu medic
That's the fault of the FDA who failed Relenza and patients by...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online